ArticleAmerican journal of cancer research2020

Anti-PD-1 antibody SHR-1210 plus apatinib for metastatic colorectal cancer: a prospective, single-arm, open-label, phase II trial.

Chao Ren et al.PubMed ↗Full text ↗

No numbers read from the abstract.